Strong modelling starts with the right foundation. This session explores how Phoenix NLME and RsNLME support early phase clinical pharmacology workflows where speed, clarity, and confident decision making are key.
Learn how flexible tools, a robust model fitting engine, and streamlined workflows help you stay efficient, even when switching tools or updating data. Real world examples include a translational use case and an exposure response analysis.
Introduction: A toolset designed around the modeler
Keith Nieforth, PharmD, Senior Director, Pharmacometrics Software, Certara
Use cases covered:
Dose proportionality in a first in human study
Elliot Offman, BSc Pharm, MSc, PhD, Vice President, Clinical Pharmacology & Translational Medicine, Certara Drug Development Solutions
Adverse event probability modeling with RsNLME
Mahmoud Ali, BSc Pharm, MSc, Associate Scientist, Certara Drug Development Solutions
Ideal for:
- Quantitative Clinical Pharmacologists
- Translational Pharmacologists
- PK/PD Modelers
